
About Martinsynge Pharma Sciences Private Limited
Data last updated:
Martinsynge Pharma Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Bondbay Pharmaceuticals Private Limited. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 17 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74900TG2015PTC098547. Its GSTIN is 36AAJCM6965C1Z8 (Telangana).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹80 Lakh. It is led by directors Swathi Gandra and Swarna Latha Goli.
Its last annual general meeting (AGM) was held on 30 September 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2022, the company reported a revenue of ₹24.58 Lakh, a decline of 41% compared to the previous year. For the same year it recorded a net profit of ₹41,739 (net margin 1.7%) and EBITDA of ₹5.33 Lakh (EBITDA margin 21.7%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 2% over five years.
The company is associated with 1 brand: Bondbay Pharmaceuticals.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website martinsynge.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No.113&114 2nd Floor Aleap Industrial Estate Gajularamaram (Village) Quthubullapur (M, Andal), Hyderabad, Telangana, India – 500055
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Martinsynge Pharma Sciences Private Limited
The main business activity of Martinsynge Pharma Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Martinsynge Pharma Sciences Private Limited FY 2021 filings available
Martinsynge Pharma Sciences Private Limited reported revenue of ₹24.58 Lakh (down 41% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Martinsynge Pharma Sciences Private Limited
Revenue fell 41% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA rose 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Martinsynge Pharma Sciences Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹24.58 Lakh | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.33 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹41,739 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Martinsynge Pharma Sciences Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Martinsynge Pharma Sciences are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Martinsynge Pharma Sciences Private Limited
Martinsynge Pharma Sciences Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rezovate Constructions Private Limited | ₹41.81 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Bhopal, Madhya Pradesh, India |
| Chakrachem Lifesciences Private Limited | ₹41.75 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
| United Footwear Private Limited | ₹41.72 Lakh (FY 2024) | •••• | •••• | -17.0% | •••• | Chennai, Tamil Nadu, India |
| Dunex Lifecare Private Limited | ₹41.71 Lakh (FY 2025) | •••• | •••• | -90.0% | •••• | Delhi, India |
| Custom Formulations Private Limited | ₹41.66 Lakh (FY 2023) | •••• | •••• | -67.0% | •••• | Pune, Maharashtra, India |
| Florencia Healthcare Private Limited | ₹41.64 Lakh (FY 2025) | •••• | •••• | 28.0% | •••• | Delhi, India |
| Excel Medpharma Private Limited | ₹41.57 Lakh (FY 2025) | •••• | •••• | -1.0% | •••• | Kolkata, West Bengal, India |
| Sang Froid Marine Chem Private Limited | ₹41.53 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Rajkot, Gujarat, India |
| Chennai Poly Chemicals Private Limited | ₹41.5 Lakh (FY 2025) | •••• | •••• | 50.0% | •••• | Tiruvallur, Tamil Nadu, India |
| SMV Coatings Private Limited | ₹41.49 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Kanpur, Uttar Pradesh, India |
| Martinsynge Pharma Sciences Private Limited this company | ₹24.58 Lakh (FY 2022) | •••• | •••• | -41.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Martinsynge Pharma Sciences by revenue in the Chemicals industry (Formulations, Industrial Chemicals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Martinsynge Pharma Sciences Private Limited
Martinsynge Pharma Sciences Private Limited is audited by M S P R & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M S P R & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Martinsynge Pharma Sciences Private Limited
Martinsynge Pharma Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swathi Gandra | Director | 29 Oct 2018 | 7 Years 11 Months | Current |
| Swarna Latha Goli | Director | 29 Oct 2018 | 7 Years 11 Months | Current |
Ownership and Shareholding of Martinsynge Pharma Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Martinsynge Pharma Sciences Private Limited
Martinsynge Pharma Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Martinsynge Pharma Sciences Private Limited
Martinsynge Pharma Sciences operates one associated brand: Bondbay Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical raw materials, drug intermediates, and APIs for industry supply. | bondbaypharma.com |
Employees and EPFO Compliance at Martinsynge Pharma Sciences Private Limited
Employment history and EPFO contributions of people linked to Martinsynge Pharma Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Martinsynge Pharma Sciences Private Limited
Martinsynge Pharma Sciences Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Manasa Reddy Billa ceased to be Managing Director on 29 Oct 2018.
Credit Ratings, Litigation & Regulatory Alerts for Martinsynge Pharma Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Martinsynge Pharma Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Martinsynge Pharma Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Martinsynge Pharma Sciences Private Limited
Martinsynge Pharma Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCM6965C1Z8 | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Martinsynge Pharma Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Martinsynge Pharma Sciences Private Limited
Martinsynge Pharma Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 17 April 2015 (11+ years old) and is registered under CIN U74900TG2015PTC098547.
Martinsynge Pharma Sciences reported revenue of ₹24.58 Lakh for FY 2022 (down 41% YoY).
Martinsynge Pharma Sciences has 2 current directors:
- Swathi Gandra - Director
- Swarna Latha Goli - Director
Martinsynge Pharma Sciences reported a net profit of ₹41,739 (net margin 1.7%) and EBITDA of ₹5.33 Lakh (EBITDA margin 21.7%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Martinsynge Pharma Sciences is -4% over three years and 2% over five years. In the latest year (FY 2022) revenue fell 41%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Martinsynge Pharma Sciences is 36AAJCM6965C1Z8, registered in Telangana.
The CIN (Corporate Identification Number) of Martinsynge Pharma Sciences is U74900TG2015PTC098547. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Martinsynge Pharma Sciences was incorporated on 17 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Martinsynge Pharma Sciences by revenue are Rezovate Constructions Private Limited, Chakrachem Lifesciences Private Limited, United Footwear Private Limited, Dunex Lifecare Private Limited, Custom Formulations Private Limited and 5 more, all in the Chemicals industry (Formulations, Industrial Chemicals).
Manasa Reddy Billa ceased to be Managing Director on 29 Oct 2018. Srilatha Billa ceased to be Whole-Time Director on 29 Oct 2018. Swarna Latha Goli was appointed as Director on 29 Oct 2018. Martinsynge Pharma Sciences has 5 board changes on record in total.
Martinsynge Pharma Sciences can be reached through the website martinsynge.com. Its registered office is in Hyderabad, Telangana, India.